This page contains a Flash digital edition of a book.
HEALTH SCIENCES DIVISION


CARDINAL BERNARDIN CANCER CENTER


Joining forces to fight cancer Loyola and the University of


Notre Dame are joining forces against cancer. The goal of the re- search collaboration is to provide direct support for revolutionary cancer research that could make cancer a more manageable, and potentially curable, disease. Four $50,000 grants will fund


STRITCH SCHOOL OF MEDICINE THE ENVELOPE, PLEASE


At 11 a.m. on March 21, Stritch students waited with bated breath as they were handed sealed envelopes. Upon open- ing them, the students learned where they would be going for their hospital residencies.


the Loyola-Notre Dame research project. Loyola’s Cardinal Ber- nardin Cancer Center, University of Notre Dame’s Harper Cancer Research Institute, and CHE Trinity Health are funding three of the grants. A fourth grant is funded by donors Michael and Estella Cronk of Oak Brook, Illinois. The grants will provide initial


funding for four joint research projects:


• A new weapon against ovarian cancer


• Helping the immune system fight cancer


• A better model to study leukemia


Emotions run high on Match Day, when medical students learn where they’ll be placed for residency.


Stritch researcher awarded presidential honor “The impressive achievements


Katherine Radek (PhD ’05), of


the Stritch School of Medicine, has received a prestigious Presidential Early Career Award for Scientists and Engineers. It’s the highest honor bestowed by the US govern- ment on science and engineering professionals in the early stages of their research careers. Dr. Radek is among 102 researchers to receive the honor.


of these early-stage scientists and engineers are promising indicators of even greater successes ahead,” President Obama said. Radek is an assistant profes-


sor in the Department of Surgery at Stritch and a member of the University’s Burn and Shock Trauma Research Institute. She is research- ing the mechanisms by which stress


• A Trojan Horse approach to fighting melanoma, which means packaging an anti-mel- anoma drug inside nanopar- ticles so that the drug reaches a site inside the cell where it can exert its toxic effect


responses and nicotinic receptors influence the immune system in models of inflammatory skin diseases (such as atopic dermatitis and chronic wounds) and traumatic burn injury. Presidential Early Career Award


recipients are employed or funded by the Department of Health and Human Services and other federal department and agencies.


The one-year grants are


intended as seed funds for inves- tigators to establish collaborative projects that collect preliminary data needed for a competitive application to a major external funding source.


SPRING 2014


11


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44